BTTX (BTTX) Stock Price & Analysis
BTTX (BTTX) rose 0.00% to USD 0 as of September 8, 2026 at 14:52 UTC, according to Nexqual real-time market data.
BTTX last closed at USD 0; the session ranged USD 0–0 on volume of 500 shares. Market capitalization is —, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, September 8, 2026 at 14:52 UTC.
Key Statistics (as of September 8, 2026 at 14:52 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 500 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (BTTX)
Nexqual's technical model rates BTTX "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 14:52 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ABVC | ABVC Biopharma, Inc. | USD 0.99 | ▼ 0.61% |
| PTPI | Petros Pharmaceuticals, Inc. | USD 0.01 | ▲ 60% |
| BFRI | Biofrontera Inc. | USD 1.58 | ▲ 4.3% |
| EFTR | eFFECTOR Therapeutics, Inc. | USD 0 | ▲ 0% |
| NRSN | NeuroSense Therapeutics Ltd. | USD 0.5 | ▲ 25.02% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:52 UTC. This page is informational and not investment advice.